|
AMMECR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.131600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.321700E-02 |
| Normal-vs-Stage2 |
9.359400E-01 |
| Normal-vs-Stage3 |
3.167600E-01 |
| Normal-vs-Stage4 |
3.466200E-01 |
| Stage1-vs-Stage2 |
1.404960E-01 |
| Stage1-vs-Stage3 |
4.263200E-01 |
| Stage1-vs-Stage4 |
4.787800E-01 |
| Stage2-vs-Stage3 |
4.143400E-01 |
| Stage2-vs-Stage4 |
4.202200E-01 |
| Stage3-vs-Stage4 |
9.869000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.251500E-02 |
| Normal-vs-AfricanAmerican |
1.411390E-01 |
| Normal-vs-Asian |
1.841560E-01 |
| Caucasian-vs-AfricanAmerican |
8.010200E-01 |
| Caucasian-vs-Asian |
7.434600E-01 |
| AfricanAmerican-vs-Asian |
6.382400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.350200E-01 |
| Normal-vs-Female |
6.627800E-02 |
| Male-vs-Female |
6.865400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.116500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.890550E-01 |
| Normal-vs-Age(61-80Yrs) |
9.778200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.453200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.772050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.469900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.703540E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.563800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.458200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.000600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.477400E-01 |
| Classical-VS-Follicular |
1.73880021492323E-10 |
| Classical-VS-Other |
8.389700E-02 |
| Classical-VS-Normal |
5.211300E-04 |
| Tall-VS-Follicular |
9.770000E-04 |
| Tall-VS-Other |
1.918370E-01 |
| Tall-VS-Normal |
1.449230E-01 |
| Follicular-VS-Other |
7.020400E-01 |
| Follicular-VS-Normal |
7.184300E-03 |
| Other-VS-Normal |
3.913400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.991800E-01 |
| Normal-vs-N1 |
2.527600E-01 |
| N0-vs-N1 |
2.521000E-01 |
|
|
